1110 Stock Chart & Stats
€0.06
€0.00(0.00%)
At close: 4:00 PM EST
€0.06
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.06 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€12.54M
Enterprise Value€8.63M
Total Cash (Recent Filing)€3.59M
Total Debt (Recent Filing)€3.05M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,664,534
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.66
Price to Sales (P/S)10.52
P/FCF Ratio-1.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.46Price Target Upside14002.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Industrial Revenue TractionThe sharp increase in industrial ceramics revenue and initial shipment conversion demonstrate emerging commercial traction beyond development-stage activity. If sustained, this customer demand can broaden the revenue base, support manufacturing scale, and help fund continued investment in medical technologies.
FDA-cleared Medical PlatformFDA clearance, early clinical use, and an established distributor network provide an important commercialization foundation for SINTX’s silicon nitride orthopedic products. These milestones can support physician access, customer adoption, and recurring product demand as limited-use review expands.
Improved Gross MarginThe significant improvement in gross profit and reported margin indicates that higher-margin product sales, improved OEM pricing, and favorable mix can materially improve unit economics. Maintaining these drivers would strengthen the path toward operating leverage as commercial volumes increase.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flow means the business is not yet funding its operations internally. Continued burn can consume available liquidity, restrict investment flexibility, and require additional financing before commercial growth translates into self-sustaining cash generation.
Going-concern And Liquidity RiskThe low cash balance and explicit going-concern disclosure create a durable financing risk while losses and operating cash use continue. Reliance on additional equity or debt can increase dilution, raise funding costs, and limit management’s ability to execute its growth plans independently.
Uncertain Order ConversionAnnounced purchase orders do not guarantee recognized revenue because several technical and customer milestones must be completed first. Delays in qualified production, yields, shipment, acceptance, or collection could make revenue uneven and reduce the near-term benefits of reported commercial visibility.
1110 FAQ
What was Sintx Technologies Inc’s price range in the past 12 months?
Sintx Technologies Inc lowest stock price was €0.06 and its highest was €0.07 in the past 12 months.
What is Sintx Technologies Inc’s market cap?
Sintx Technologies Inc’s market cap is €12.54M.
When is Sintx Technologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sintx Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Sintx Technologies Inc overvalued?
According to Wall Street analysts Sintx Technologies Inc’s price is currently Undervalued.
Does Sintx Technologies Inc pay dividends?
Sintx Technologies Inc does not currently pay dividends.
What is Sintx Technologies Inc’s EPS estimate?
Sintx Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sintx Technologies Inc have?
Sintx Technologies Inc has 6,664,534 shares outstanding.
What happened to Sintx Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sintx Technologies Inc?
Currently, no hedge funds are holding shares in DE:1110
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sintx Technologies Inc
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
1110 Earnings Call
Q2 2026
0:00 / 0:00
1110 Stock 12 Month Forecast
Average Price Target
€8.46
▲(14002.74% Upside)
Technical Analysis
Integra Lifesciences
―
Medtronic
―
Orthofix Medical
―
Stryker
―
Zimmer Biomet Holdings
―








